299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

42 trials found

diseases per page:

Showing 1 to 10 of 42 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02712983 (ClinicalTrials.gov)	February 8, 2017	5/2/2016	Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder i ...	A Randomized, Blinded, Parallel Group, Multi-center Dose-finding Study, to Assess the Efficacy, Safe ...	Non-cystic Fibrosis Bronchiectasis	Drug: TIP;Drug: TIP and placebo;Drug: Placebo	Novartis Pharmaceuticals	Queen's University Belfast, UK;University Hospital Antwerp, BE;University of Milan, IT;Fundacion Cli ...	Completed	18 Years	N/A	All	107	Phase 2	Belgium;France;Germany;Italy;Spain;United Kingdom;Netherlands
2	NCT02248922 (ClinicalTrials.gov)	January 27, 2015	22/9/2014	Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa	An 8 Week Open-label Interventional Multicenter Study to Evaluate the Lung Clearance Index as Endpoi ...	Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis	Drug: TIS or TIP	Novartis Pharmaceuticals	NULL	Terminated	6 Years	N/A	All	17	Phase 4	Germany
3	NCT02212587 (ClinicalTrials.gov)	September 2014	6/8/2014	Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Co ...	Pilot Study of the in Vivo Efficacy of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patient ...	Cystic Fibrosis;Burkholderia Cepacia Infection	Drug: TOBI	St. Michael's Hospital, Toronto	NULL	Completed	6 Years	N/A	All	10	Phase 1	Canada
4	NCT02015663 (ClinicalTrials.gov)	January 2014	13/12/2013	Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIPAdministered BID i ...	A 24-week, Open-label, Parallel-group, Interventional Phase IV Study Comparing Tobramycin Inhalation ...	Cystic Fibrosis	Drug: Tobramycin Inhalation Powder	Novartis Pharmaceuticals	NULL	Terminated	6 Years	N/A	All	32	Phase 4	United States
5	NCT01844778 (ClinicalTrials.gov)	August 2013	29/4/2013	Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobra ...	An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIPWith Nebuli ...	Cystic Fibrosis	Drug: Tobramycin Inhalation Powder;Drug: Tobramycin inhalation solution;Drug: Colistimethate	Novartis Pharmaceuticals	NULL	Completed	6 Years	N/A	All	60	Phase 4	Germany;Ireland;Spain;Switzerland;United Kingdom
6	EUCTR2012-003532-23-DE (EUCTR)	20/06/2013	05/02/2013	An extension of a clinical study to investigate long term safety of tobramycin inhalation powder (TI ...	A 48 week extension to CTBM100C2401, a single arm open-label, multicenter, phase IV trial, to assess ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 15.1; ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 4	France;United States;Hungary;Mexico;Canada;Argentina;Spain;Australia;Germany;Italy
7	NCT01775137 (ClinicalTrials.gov)	February 2013	22/1/2013	Ext. Long-term Safety Study in CF Patients: Single Arm TIP	A 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial ...	Long-term Safety of TIP	Drug: TBM100	Novartis Pharmaceuticals	NULL	Completed	6 Years	N/A	All	45	Phase 4	United States;Argentina;Australia;Canada;Germany;Hungary;Italy;Mexico;Spain
8	EUCTR2012-003532-23-ES (EUCTR)	29/01/2013	29/11/2012	An extension of a clinical study to investigate long term safety of tobramycin inhalation powder (TI ...	A 48 week extension to CTBM100C2401, a single arm open-label, multicenter, phase IV trial, to assess ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1; ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Farmaceutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 4	France;United States;Hungary;Mexico;Canada;Argentina;Spain;Australia;Germany;Italy
9	EUCTR2012-003532-23-IT (EUCTR)	18/01/2013	21/12/2012	An extension of a clinical study to investigate long term safety of tobramycin inhalation powder (TI ...	A 48 week extension to CTBM100C2401, a single arm open-label, multicenter, phase IV trial, to assess ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1; ...	Trade Name: TOBI PODHALER*448CPS 28MG+10IN INN or Proposed INN: Tobramycin	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 4	United States;Hungary;Mexico;Canada;Argentina;Spain;Australia;Germany;Italy
10	EUCTR2012-003532-23-HU (EUCTR)	19/12/2012	31/10/2012	An extension of a clinical study to investigate long term safety of tobramycin inhalation powder (TI ...	A 48 week extension to CTBM100C2401, a single arm open-label, multicenter, phase IV trial, to assess ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1; ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 4	France;United States;Hungary;Mexico;Canada;Argentina;Spain;Australia;Germany;Italy

First Previous1 2 3 4 5Next Last